Jussi Rytkonen

Charles River
Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Physiological and behavioural implications of the portosystemic shunt in C57Bl/6J mice.

Physiological and behavioural implications of the portosystemic shunt in C57Bl/6J mice.

Journal: The Journal of physiology

Published: July 05, 2024

A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease.

A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease.

Journal: Progress in neurobiology

Published: June 19, 2019

Improved synthesis of [18F] fallypride and characterization of a Huntington's disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors.

Improved synthesis of [18F] fallypride and characterization of a Huntington's disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 06, 2019

Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid Injection.

Integrin α4 Overexpression on Rat Mesenchymal Stem Cells Enhances Transmigration and Reduces Cerebral Embolism After Intracarotid Injection.

Journal: Stroke

Published: June 20, 2017

Electrostatic interaction on loading of therapeutic peptide GLP-1 into porous silicon nanoparticles.

Electrostatic interaction on loading of therapeutic peptide GLP-1 into porous silicon nanoparticles.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: January 22, 2015

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Journal: Acta biomaterialia

Published: June 13, 2014

Nanocarriers and the delivered drug: effect interference due to intravenous administration.

Nanocarriers and the delivered drug: effect interference due to intravenous administration.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 28, 2014

Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

Journal: Molecular pharmaceutics

Published: December 18, 2013

Peptide labelling strategies for imaging agents.

Peptide labelling strategies for imaging agents.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 23, 2013

Novel systemically active galanin receptor 2 ligands in depression-like behavior.

Novel systemically active galanin receptor 2 ligands in depression-like behavior.

Journal: Journal of neurochemistry

Published: November 27, 2012

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.

Journal: Journal of drug delivery

Published: February 22, 2012

Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.

Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.

Journal: Molecular pharmaceutics

Published: January 27, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026